SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-007253
Filing Date
2024-02-27
Accepted
2024-02-27 16:34:07
Documents
6
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 arcutiss-8xfebruary2024.htm S-8 65140
2 EX-FILING FEES exhibit107-feetablefebruar.htm EX-FILING FEES 16583
3 EX-5.1 exhibit51-sx8xfebruary2024.htm EX-5.1 19294
4 EX-23.2 exhibit232-sx8xfebruary2024.htm EX-23.2 2452
5 image_0a.jpg GRAPHIC 49249
6 logo1ba.jpg GRAPHIC 98116
  Complete submission text file 0001628280-24-007253.txt   302669
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277405 | Film No.: 24687500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)